MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmj-2023-076197

Медицинская библиотека · BMJ (Clinical research ed.) · 2023

A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study.

Woolf Benjamin, Rajasundaram Skanda, Cronjé Héléne T, Yarmolinsky James, Burgess Stephen, Gill Dipender

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

To investigate the association of genetically proxied (using a surrogate biomarker) inhibition of phosphodiesterase 5 (PDE5), an established drug target for erectile dysfunction, with fertility, sexual behaviour, and subjective wellbeing.

DESIGN

Two sample cis-mendelian randomisation study.

SETTING

Summary data on genetic associations obtained from the International Consortium for Blood Pressure and UK Biobank.

PARTICIPANTS

Individuals of European ancestry from the International Consortium for Blood Pressure (n=757 601) for estimating PDE5 inhibition (using the surrogate biomarker of diastolic blood pressure reduction), and UK Biobank (n=211 840) for estimating the fertility, sexual behaviour, and subjective wellbeing outcomes in male participants.

INTERVENTION: Genetically proxied PDE5 inhibition.

MAIN OUTCOME MEASURES: Number of children fathered, number of sexual partners, probability of never having had sexual intercourse, and subjective wellbeing.

RESULTS

Genetically proxied PDE5 inhibition was associated with male participants having 0.28 (95% confidence interval 0.16 to 0.39) more children (false discovery rate corrected P<0.001). This association was not identified in female participants. No evidence was found of an association between genetically proxied PDE5 inhibition and number of sexual partners, probability of never having had sexual intercourse, or self-reported wellbeing in male participants.

CONCLUSIONS

The findings of this study provide genetic support for PDE5 inhibition potentially increasing the number of children fathered by male individuals. Absence of this association in female participants supports increased propensity for sustained and robust penile erections as a potential underlying mechanism. Further studies are required to confirm this, however, and these findings should not promote indiscriminate use of PDE5 inhibitors, which can also have harmful adverse effects.

Для цитирования: Woolf Benjamin, Rajasundaram Skanda, Cronjé Héléne T, Yarmolinsky James, Burgess Stephen, Gill Dipender. A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study.. BMJ (Clinical research ed.). 2023. DOI: 10.1136/bmj-2023-076197.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.